title: Pseudotumor cerebri induced by minocycline therapy for acne vulgaris.
abstract: BACKGROUND
  We report a case of a young girl who developed pseudotumor cerebri while taking minocycline for acne vulgaris.
  
  
  METHODS
  A 16-year-old girl without a history of menstrual irregularity, weighing 60 kg (body mass index: 26.0%) presented with a history of 1 week of headache and sudden onset of a horizontal diplopia.
  
  
  METHODS
  Examination revealed bilateral papilledema and an abduction deficit in her right eye. Her cerebrospinal fluid had an opening pressure of 400 mm H(2)O and a normal composition. Following normal findings on computed tomography and magnetic resonance imaging, a diagnosis of pseudotumor cerebri was made. She reported receiving minocycline to treat acne vulgaris during the previous 3 weeks. The headache resolved with withdrawal of minocycline. The diplopia and papilledema resolved after two lumbar punctures, although the visual field defects persisted. The minocycline concentrations in the serum and cerebrospinal fluid taken after cessation of the drug were below the detectable level.
  
  
  CONCLUSIONS
  The role of minocycline should be considered and routine ophthalmologic examination during minocycline treatment should be performed when pseudotumor cerebri occurs in patients treated for acne vulgaris.
authors.affiliation: Department of Ophthalmology, JA Gifu Koseiren, Chuno General Hospital, Gifu, Japan.
authors.forename: Kiyofumi
authors.initials: K
authors.lastname: Mochizuki
authors.forename: Tomoko
authors.initials: T
authors.lastname: Takahashi
authors.forename: Michihisa
authors.initials: M
authors.lastname: Kano
authors.forename: Keiichi
authors.initials: K
authors.lastname: Terajima
authors.forename: Nobuhide
authors.initials: N
authors.lastname: Hori
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004172:Diplopia / Q000139:chemically induced; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008911:Minocycline / Q000009:adverse effects* / Q000627:therapeutic use; D010211:Papilledema / Q000139:chemically induced; D011559:Pseudotumor Cerebri / Q000139:chemically induced*; D014057:Tomography, X-Ray Computed; D014792:Visual Acuity; D014794:Visual Fields
chemical_list: D000900:Anti-Bacterial Agents; D008911:Minocycline